XML 31 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Segment and Geographic Data
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
We segregate our operations into two reportable business
segments: (i) MedSurg and Neurotechnology and (ii)
Orthopaedics which aligns to our internal reporting structure and
how our Chief Operating Decision Maker (CODM) assesses the
performance of and allocates resources. The CODM is the Chief
Executive Officer. The CODM makes decisions on resource
allocation, assesses performance of the business, and monitors
budget versus actual results using segment operating income.
Our reportable segments and related disclosures reflect certain
reclassifications of prior year amounts from our Orthopaedics
segment to our MedSurg and Neurotechnology segment due to
changes in our internal reporting structure.
Segment Results
Three Months
Six Months
2025
2024
2025
2024
MedSurg and Neurotechnology
$3,771
$3,215
$7,282
$6,312
Orthopaedics
2,251
2,207
4,606
4,353
Net sales
$6,022
$5,422
$11,888
$10,665
MedSurg and Neurotechnology
$1,414
$1,287
$2,736
$2,525
Orthopaedics
599
576
1,228
1,167
Cost of sales
$2,013
$1,863
$3,964
$3,692
MedSurg and Neurotechnology
$246
$194
$471
$389
Orthopaedics
127
136
267
270
Segment research, development and
engineering expenses
$373
$330
$738
$659
MedSurg and Neurotechnology
$984
$775
$1,921
$1,538
Orthopaedics
743
756
1,590
1,507
Segment selling, general and
administrative expenses
$1,727
$1,531
$3,511
$3,045
MedSurg and Neurotechnology
$58
$56
$115
$110
Orthopaedics
104
105
202
213
Segment depreciation and
amortization
$162
$161
$317
$323
Corporate and Other
$40
$38
$79
$78
Amortization of intangible assets
187
155
354
308
Total depreciation and amortization
$389
$354
$750
$709
MedSurg and Neurotechnology
$1,069
$903
$2,039
$1,750
Orthopaedics
678
634
1,319
1,196
Segment operating income
$1,747
$1,537
$3,358
$2,946
Items not allocated to segments:
Corporate and Other
$(202)
$(203)
$(469)
$(466)
Inventory stepped up to fair value
(65)
(9)
(99)
(9)
Acquisition and integration-related
charges
(78)
(14)
(263)
(1)
Amortization of intangible assets
(187)
(155)
(354)
(308)
Structural optimization and other special
charges
(11)
(59)
(52)
(70)
Goodwill and other impairments
(55)
(16)
(90)
(19)
Medical device regulation
(7)
(15)
(19)
(28)
Recall-related matters
(22)
(17)
(55)
(22)
Regulatory and legal matters
(7)
2
(7)
—
Consolidated operating income
$1,113
$1,051
$1,950
$2,023
Segment Assets
June 30
December 31
2025
2024
Assets:
MedSurg and Neurotechnology
$26,909
$23,115
Orthopaedics
17,865
18,507
Total segment assets
$44,774
$41,622
Corporate and Other
1,557
1,349
Total assets
$46,331
$42,971